NYRADA INC.

9.68%

$1.02

Market Cap $0

Healthcare Biotechnology

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Latest Threads

Tag

Subject

NYR

What’s next for NYR

8 9 10

18:23

564

85K

18:23

Last post Wineman71

564

85K

NYR

Ann: Application for quotation of securities - NYR

05:53

1.4K

05:53

Last post Bendunstan

1.4K

NYR

Ann: Quarterly Activities Report and Appendix 4C

23/01/26

8.2K

23/01/26

Last post dsa69

8.2K

NYR

CHART

20 21 22

23/01/26

1.2K

211K

23/01/26

Last post Bendunstan

1.2K

211K

NYR

Ann: Cleansing Statement

23/01/26

161

23/01/26

Last post

ASX News

161

NYR

PART 2 - USA Peer Analysis

7 8 9

22/01/26

532

86K

22/01/26

Last post jason_695

532

86K

NYR

Ann: Change of Director's Interest Notice - ID

20/01/26

3.9K

20/01/26

Last post 4thtime

3.9K

NYR

Ann: Notification of cessation of securities - NYR

19/01/26

2.1K

19/01/26

Last post Bendunstan

2.1K

See All Discussions

Timeline

Cleansing Statement
23 Jan 14:23	Share

Application for quotation of securities - NYR
23 Jan 14:22	Share

Quarterly Activities Report and Appendix 4C
23 Jan 08:52	Share

Change of Director's Interest Notice - ID
19 Jan 13:28	Share

Notification of cessation of securities - NYR
19 Jan 08:29	Share

Cleansing Statement
13 Jan 17:46	Share

Application for quotation of securities - NYR
13 Jan 17:44	Share

Cleansing Statement
12 Jan 15:15	Share

Application for quotation of securities - NYR
12 Jan 15:14	Share

Nyrada Phase IIa Clinical Trial Approved to Commence
08 Jan 11:12	Share

Cleansing Statement
06 Jan 14:22	Share

Application for quotation of securities - NYR
06 Jan 14:18	Share

Cleansing Statement
31 Dec 12:21	Share

Application for quotation of securities - NYR
31 Dec 12:20	Share

Change of Director's Interest Notice - ID
22 Dec 08:29	Share

Upcoming Expiry of Unlisted Options
19 Dec 09:13	Share

Change of Director's Interest Notice - JM
10 Dec 09:53	Share

Change of Director's Interest Notice - MF
10 Dec 09:53	Share

Change of Director's Interest Notice - RW
10 Dec 09:53	Share

Change of Director's Interest Notice - CC
10 Dec 09:52	Share

Cleansing Statement
10 Dec 09:45	Share

Application for quotation of securities - NYR
10 Dec 09:44	Share

Change of Director's Interest Notice - JM
05 Dec 18:33	Share

Change of Director's Interest Notice - MF
05 Dec 18:33	Share

Change of Director's Interest Notice - RW
05 Dec 18:33	Share

Cleansing Statement
05 Dec 18:29	Share

Application for quotation of securities - NYR
05 Dec 18:28	Share

Investor Presentation
26 Nov 08:26	Share

Capital Structure
25 Nov 09:51	Share

Cleansing Statement
24 Nov 16:08	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.02		Change 0.090(9.68%)		Mkt cap ! N/A

Open	High	Low	Volume
98.0¢	$1.05	97.0¢	975.6K

Buyers (Bids)

Vol.	Price($)
2010	$1.01

Sellers (Offers)

Price($)	Vol.
$1.02	14201

Last trade - 16.18pm 23/01/2026 (20 minute delay)

NYR (ASX) Chart

NYRADA INC.

Corporate Spotlight
Not Yet Available

Latest Threads

Timeline

Featured News

Latest Articles

Nyrada pushes through to third cohort in Phase 1 trial for NYR-BI03

Nyrada Inc has been given the go-ahead to a third cohort in its Phase 1 clinical trial into its drug for neuroprotection and cardioprotection

Study finds Nyrada's lead drug can prevent secondary brain injury

Nyrada Inc has reported strong results from a collaborative study it has been engaged in regarding its lead candidate NYR-BI03

Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug

Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to assess the safety and tolerability of NYR-BI03

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

NYRADA INC.

Corporate SpotlightNot Yet Available

Latest Threads

Timeline

Featured News

Latest Articles

Nyrada pushes through to third cohort in Phase 1 trial for NYR-BI03

Nyrada Inc has been given the go-ahead to a third cohort in its Phase 1 clinical trial into its drug for neuroprotection and cardioprotection

Study finds Nyrada's lead drug can prevent secondary brain injury

Nyrada Inc has reported strong results from a collaborative study it has been engaged in regarding its lead candidate NYR-BI03

Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug

Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to assess the safety and tolerability of NYR-BI03

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News

Corporate Spotlight
Not Yet Available